Alka and haemorrhage Patient Reports February 12, 2012

Alka Side Effects Report #5240266-1
Alka side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2007. Female patient, weighting 185.2 lb, was diagnosed with dyspepsia and was treated with Alka. After drug was administered, patient experienced the following side effects: haemorrhage, urticaria. Alka dosage: TOTAL DAILY DOSE: 650 MG UNIT DOSE: 325 MG. Patient was hospitalized. Patient died.

Alka Side Effects Report #5242443-2
Alka side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Female patient, weighting 185.2 lb, was diagnosed with dyspepsia and was treated with Alka. After drug was administered, patient experienced the following side effects: haemorrhage, urticaria. Alka dosage: TOTAL DAILY DOSE: 650 MG UNIT DOSE: 325 MG. Patient was hospitalized. Patient died.

Alka Side Effects Report #5243969-8
Alka side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Female patient, weighting 185.2 lb, was diagnosed with dyspepsia and was treated with Alka. After drug was administered, patient experienced the following side effects: haemorrhage, urticaria. Alka dosage: TOTAL DAILY DOSE: 650 MG UNIT DOSE: 325 MG. Patient was hospitalized. Patient died.

Alka Side Effects Report #5281338-5
Alka side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 26, 2007. Female patient, weighting 185.2 lb, was diagnosed with dyspepsia and was treated with Alka. After drug was administered, patient experienced the following side effects: haemorrhage, urticaria. Alka dosage: TOTAL DAILY DOSE: 650 MG UNIT DOSE: 325 MG. Patient was hospitalized. Patient died.


Alka Side Effects Report #4703054-8
Alka side effect was reported by a Pharmacist from on June 28, 2005. Male patient, 47 years of age, weighting 145.5 lb, was treated with Alka. After drug was administered, patient experienced the following side effects: disease recurrence, haematemesis, haemorrhage, melaena. Alka dosage: unknown. During the same period patient was treated with PREVPAC. Patient was hospitalized. Patient recovered.